Equilin inhibited 3βHSD1 activity better than BCA in different prostate cancer cells, with an IC50 around 2.8 nM in VCaP cells (Figure 9C and Supplemental Figure 10, A–C). The gene discussed is BLNK; the disease is prostate carcinoma.